In addition to its female-specific effects, our genetic analyses demonstrate that sST2/rs1921622 plays disease-causing effects in females with AD, specifically those carrying APOE-ε4, suggesting a potential interaction between IL-33–ST2 signaling and ApoE. Here, IL33 is linked to Alzheimer disease.